Antares Pharma, Inc. (ATRS)

[H2R]

Starting to be more visible? SA's new ATRS article:

https://seekingalpha.com/article/4060140-antares-pharma-set-multiple-catalysts-2017

The article has a bit of depth. The summary is below:

Summary

As the company fulfills its robust pipeline of FDA approvals over the next 24 months, the remaining nine months of 2017 will likely be action-packed.

Existing FDA approved products alone will drive double-digit revenue growth in 2017.

Three likely FDA approvals in 2017 should power the shares much higher by year end.

While the company maintains excellent long-term fundamentals, the article will focus on expected results in 2017.